申请人:Pfizer Limited
公开号:EP0072623A1
公开(公告)日:1983-02-23
Compounds of the general formula:
wherein R is hydrogen, C1-C4 alkyl, C3-C7 cycloalkyl, CONH2, CON(C1-C4 alkyl)2, or substituted C1-C4 alkyl wherein the substituent is N(C1-C4 alkyl)2, one or two OH groups, CONH2, CON(C1-C4 lower alkyl)2 or cycloalkyl; Ar is phenyl optionally substituted by one or two halogen atoms, C,-C4 alkyl or C1-C4 alkoxy groups; and pharmaceutically acceptable acid addition salts thereof are antifungal agents useful in combating fungal infections in animals, including humans.
通式如下的化合物:其中 R 是氢、C1-C4 烷基、C3-C7 环烷基、CONH2、CON(C1-C4 烷基)2 或取代的 C1-C4 烷基,其中取代基是 N(C1-C4烷基)2、一个或两个 OH 基团、CONH2、CON(C1-C4 低级烷基)2 或环烷基;Ar 是任选被一个或两个卤素原子、C,-C4 烷基或 C1-C4 烷氧基取代的苯基;及其药学上可接受的酸加成盐是抗真菌剂,可用于防治动物(包括人类)的真菌感染。